Indeed, a survival analysis conducted on breast cancer patients using the Cbioportal database reveals a significant correlation between low expression of SIRT7 and unfavorable patient outcomes, supporting a role of SIRT7 as a tumor suppressor in this cancer type (Supplementary Figure S3A). Here, SIRT7 is linked to breast cancer.